LA JOLLA PHARMACEUTICAL COMPANY - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
77665497
Word Mark
LA JOLLA PHARMACEUTICAL COMPANY
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2009-11-27
Filing Date
2009-02-06
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
FROMM, MARTHA L
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMACEUTICAL COMPANY"
Description of Mark
The mark consists of the words LA JOLLA in stylized letters with the words PHARMACEUTICAL COMPANY underneath.
Goods and Services
Pharmaceutical preparations for the treatment of antibody-mediated diseases
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2009-02-10
Primary Code
005
Correspondences
Name
JENNIFER LEE TAYLOR
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2009-02-10 | NEW APPLICATION ENTERED IN TRAM |
2009-02-10 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2009-04-24 | ASSIGNED TO EXAMINER |
2009-05-01 | NON-FINAL ACTION WRITTEN |
2009-05-01 | NON-FINAL ACTION MAILED |
2009-11-27 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2009-11-27 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |